Product NDC: | 0179-0026 |
Proprietary Name: | Carbamazepine |
Non Proprietary Name: | Carbamazepine |
Active Ingredient(s): | 200 mg/1 & nbsp; Carbamazepine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-0026 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020234 |
Marketing Category: | NDA |
Start Marketing Date: | 20091028 |
Package NDC: | 0179-0026-70 |
Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0179-0026-70) |
NDC Code | 0179-0026-70 |
Proprietary Name | Carbamazepine |
Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0179-0026-70) |
Product NDC | 0179-0026 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Carbamazepine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20091028 |
Marketing Category Name | NDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | CARBAMAZEPINE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |